![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1309, 2001-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bosentan effective in severe pulmonary hypertension
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bosentan: In Pediatric Patients with Pulmonary Arterial Hypertension
By Carter Natalie J. Keating Gillian M.
Pediatric Drugs, Vol. 12, Iss. 1, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bosentan shows EARLY potential in pulmonary hypertension
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-term benefits of bosentan in pulmonary arterial hypertension
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bosentan: haemodynamic role in pulmonary arterial hypertension
Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. :